Why Lemelson Capital Is Short On Ligand Pharmaceuticals
October 17, 2014 at 15:52 PM EDT
Rev. Emmanuel Lemelson is the Chief Investment Officer of Lemelson Capital Management, and investment firm that is short in Ligand ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.